CFO, Principal Financial Officer & Principal Accounting OfficerMr. William E. Duke, Jr., is the Chief Financial Officer of Pulmatrix, Inc. Prior to joining our company, Mr. Duke served as the chief financial officer of Valeritas, a medical technology company, from January 2014 until June 2015 and from July 2011 until January 2014, he served as Valeritass Vice President and Corporationrationrate Controller. At Valeritas, Mr. Duke led the controller relationship, financial planning and analysis, investor relations and information technology functions. Prior to joining Valeritas, Mr. Duke was Senior Director, Finance for Genzyme Corporationrationration, a biopharmaceutical company, from January 2010 to July 2011, where he had oversight responsibility for external reporting to the Securities and Exchange Commission, internal management reporting and worldwide financial consolidation. Prior to Genzyme, he was the Director of Finance and Accounting of Haemonetics Corporationrationration, a medical device company, from May 2008 to January 2010 and held various senior financial roles with consulting services and emerging growth organizations
Age: 42 CFO Since 2015 MBADuke holds a B.S. in Accounting from Stonehill College and a M.B.A. with a concentration in Finance from Bentley University and is a Certified Public Accountant.